G1 THERAPEUTICS, INC. Operating Income
G1 THERAPEUTICS, INC. reported Operating Income of -$3.54 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-08-08
- G1 THERAPEUTICS, INC. operating income (loss) for the quarter ending 2024-06-30 was -$3.54M, a 130.70% decline year-over-year.
- G1 THERAPEUTICS, INC. operating income (loss) for the quarter ending 2024-03-31 was -$9.05M.
- G1 THERAPEUTICS, INC. operating income (loss) for the quarter ending 2023-12-31 was -$8.93M.
- G1 THERAPEUTICS, INC. operating income (loss) for the quarter ending 2023-09-30 was -$16.37M.
- G1 THERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$39.53M.
- G1 THERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$136.18M.
- G1 THERAPEUTICS, INC. operating income (loss) for fiscal 2021 was -$142.46M.
- G1 THERAPEUTICS, INC. operating income (loss) for fiscal 2020 was -$96.48M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$3.54M 10-Q · filed 2024-08-08 | -$12.58M 10-Q · filed 2024-08-08 | -$21.51M derived: sum of 3 quarters · filed 2024-08-08 | -$37.88M derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | -$9.05M 10-Q · filed 2024-05-01 | -$17.98M derived: sum of 2 quarters · filed 2024-05-01 | -$34.34M derived: sum of 3 quarters · filed 2024-05-01 | -$22.83M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | -$8.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$25.30M derived: sum of 2 quarters · filed 2024-02-28 | -$13.78M derived: sum of 3 quarters · filed 2024-08-08 | -$39.53M 10-K · filed 2024-02-28 |
| 2023-09-30 | -$16.37M 10-Q · filed 2023-11-01 | -$4.85M derived: sum of 2 quarters · filed 2024-08-08 | -$30.60M 10-Q · filed 2023-11-01 | -$61.48M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $11.52M 10-Q · filed 2024-08-08 | -$14.23M 10-Q · filed 2024-08-08 | -$45.12M derived: sum of 3 quarters · filed 2024-08-08 | -$66.67M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$25.75M 10-Q · filed 2024-05-01 | -$56.63M derived: sum of 2 quarters · filed 2024-05-01 | -$78.18M derived: sum of 3 quarters · filed 2024-05-01 | -$115.14M derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | -$30.89M 10-K · filed 2023-03-01 | -$52.44M derived: sum of 2 quarters · filed 2023-11-01 | -$89.40M derived: sum of 3 quarters · filed 2023-11-01 | -$136.18M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$21.55M 10-Q · filed 2023-11-01 | -$58.51M derived: sum of 2 quarters · filed 2023-11-01 | -$105.29M 10-Q · filed 2023-11-01 | -$142.88M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | -$36.96M 10-Q · filed 2023-08-02 | -$83.74M 10-Q · filed 2023-08-02 | -$121.33M derived: sum of 3 quarters · filed 2023-08-02 | -$162.47M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$46.78M 10-Q · filed 2023-05-03 | -$84.37M derived: sum of 2 quarters · filed 2023-05-03 | -$125.51M derived: sum of 3 quarters · filed 2023-05-03 | -$163.70M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | -$37.59M 10-K · filed 2023-03-01 | -$78.73M derived: sum of 2 quarters · filed 2023-03-01 | -$116.92M derived: sum of 3 quarters · filed 2023-03-01 | -$142.46M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$41.14M 10-K · filed 2023-03-01 | -$79.34M derived: sum of 2 quarters · filed 2023-03-01 | -$104.87M 10-Q · filed 2022-11-02 | -$128.96M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$38.19M 10-K · filed 2023-03-01 | -$63.73M 10-Q · filed 2022-08-03 | -$87.81M derived: sum of 3 quarters · filed 2023-03-01 | -$97.56M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$25.54M 10-K · filed 2023-03-01 | -$49.62M derived: sum of 2 quarters · filed 2023-03-01 | -$59.37M derived: sum of 3 quarters · filed 2023-03-01 | -$90.19M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$24.09M 10-K · filed 2022-02-23 | -$33.83M derived: sum of 2 quarters · filed 2022-02-23 | -$64.66M derived: sum of 3 quarters · filed 2022-02-23 | -$96.48M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$9.74M 10-K · filed 2022-02-23 | -$40.57M derived: sum of 2 quarters · filed 2022-02-23 | -$72.39M 10-Q · filed 2021-11-03 | -$108.94M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | -$30.82M 10-K · filed 2022-02-23 | -$62.64M 10-Q · filed 2021-08-04 | -$99.20M derived: sum of 3 quarters · filed 2022-02-23 | -$133.22M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | -$31.82M 10-K · filed 2022-02-23 | -$68.37M derived: sum of 2 quarters · filed 2022-02-23 | -$102.40M derived: sum of 3 quarters · filed 2022-02-23 | -$134.98M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | -$36.55M 10-K · filed 2021-02-24 | -$70.58M derived: sum of 2 quarters · filed 2021-02-24 | -$103.16M derived: sum of 3 quarters · filed 2021-02-24 | -$129.04M 10-K · filed 2022-02-23 |
| 2019-09-30 | -$34.02M 10-K · filed 2021-02-24 | -$66.61M derived: sum of 2 quarters · filed 2021-02-24 | -$92.49M 10-Q · filed 2020-11-04 | -$118.57M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$32.58M 10-K · filed 2021-02-24 | -$58.47M 10-Q · filed 2020-08-05 | -$84.55M derived: sum of 3 quarters · filed 2021-02-24 | -$105.37M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$25.88M 10-K · filed 2021-02-24 | -$51.97M derived: sum of 2 quarters · filed 2021-02-24 | -$72.79M derived: sum of 3 quarters · filed 2021-02-24 | -$94.44M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$26.09M 10-K · filed 2020-02-26 | -$46.91M derived: sum of 2 quarters · filed 2020-02-26 | -$68.56M derived: sum of 3 quarters · filed 2020-02-26 | -$89.29M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$20.82M 10-K · filed 2020-02-26 | -$42.48M derived: sum of 2 quarters · filed 2020-02-26 | -$63.20M 10-Q · filed 2019-11-05 | -$80.48M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | -$21.65M 10-K · filed 2020-02-26 | -$42.38M 10-Q · filed 2019-08-07 | -$59.66M derived: sum of 3 quarters · filed 2020-02-26 | -$75.59M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$20.73M 10-K · filed 2020-02-26 | -$38.01M derived: sum of 2 quarters · filed 2020-02-26 | -$53.94M derived: sum of 3 quarters · filed 2020-02-26 | -$69.31M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$17.28M 10-K · filed 2019-02-28 | -$33.21M derived: sum of 2 quarters · filed 2019-02-28 | -$48.59M derived: sum of 3 quarters · filed 2019-02-28 | -$60.97M 10-K · filed 2020-02-26 |
| 2017-09-30 | -$15.93M 10-K · filed 2019-02-28 | -$31.31M derived: sum of 2 quarters · filed 2019-02-28 | -$43.69M 10-Q · filed 2018-11-07 | -$54.09M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$15.38M 10-K · filed 2019-02-28 | -$27.76M 10-Q · filed 2018-08-08 | -$38.16M derived: sum of 3 quarters · filed 2019-02-28 | -$44.77M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$12.38M 10-K · filed 2019-02-28 | -$22.78M derived: sum of 2 quarters · filed 2019-02-28 | -$29.39M derived: sum of 3 quarters · filed 2019-02-28 | -$36.82M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$10.40M 10-K · filed 2018-02-21 | -$17.02M derived: sum of 2 quarters · filed 2018-02-21 | -$24.45M derived: sum of 3 quarters · filed 2018-02-21 | -$30.39M 10-K · filed 2019-02-28 |
| 2016-09-30 | -$6.61M 10-K · filed 2018-02-21 | -$14.04M derived: sum of 2 quarters · filed 2018-02-21 | -$19.99M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | -$7.43M 10-K · filed 2018-02-21 | -$13.38M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$5.95M 10-K · filed 2018-02-21 | |||
| 2015-12-31 | -$15.42M 10-K · filed 2018-02-21 |